维普期刊资源整合服务平台（V6.5）

278篇 您的检索式：作者名="Berek"

选中清除导出查看参考文献查看引证文献引用追踪共14页首页上一页第1页下一页末页 /14 跳转

	题名	作者	年代	出处	被引量
1	Reliability investigations on conductive adhesive joints with emphasis on the mechanics of the conduction mechanism显示文摘	Dudek R Berek H	2000	IEEE Trans Compon Packg Manuf Tech2000，23，3：	2
2	CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer显示文摘	Memarzadeh S Lee S B Berek J S	2003	Int J Gynecol Cancer2003，13，2：	1
3	Characterization of porous carbons for liquid chromatography 显示文摘	Novak I Berek D	1988	Anal Chem1988，19，：	1
4	Lower urinary tract resection as part of cytoreductive surgery for ovarian cancer显示文摘	Berek JS Hacker NF Lagasse LD	1982	Gynecol Oncol1982，13，：	1
5	Lymph node-positive stage Ⅲ C ovarian cancer: a separate entity显示文摘	Berek JS	2009	Int J Gynecol Cancer2009，19，2：	1
6	An analysis of the world's environment and population dynamics with varying carrying capacity, concerns and skepticism 显示文摘	Berek P Levy A Chowdhury K	2012	Ecological Economies2012，73，1：	1
7	Monoclonal antibody of ovarian cancer显示文摘	Nieodemus CF Berek JS	2005	Expert Rev Anticancer Ther2005，5，1：	1
8	Personalizing CA125 levels for ovarian cancer screening显示文摘	Dorigo O Berek JS	2011	Cancer Prev Res(Phila)2011，4，9：	1
9	Reliability investigations on conductive adhesive joints with emphasis on the mechanics of the conduction mechanism显示文摘	DUDEK R BEREK H FRITSCH T	2000	Components and Packaging Technologies2000，23，3：	1
10	Effects of Mycotoxins on Human Immune Functions in Vitro 显示文摘	Berek L Petri I B Mesterhazy A et a\|	2001	Toxicol In Vitro2001，15，1：	1
11	On the kinetics of inverse emul-sion polymerization of acrylamide显示文摘	Capek I FialováL Berek D	2008	Designed Monomers andPolymers2008，11，2：	1
12	Resection of diaphragmatic peritoneum and muscle:role in cytoreductive surgery for ovarian cancer显示文摘	Montz FJ Schlaerth JB Berek JS	1989	Gynecol Oncol1989，35，：	1
13	Monoclcnal antibody therapy of ovarian cancer显示文摘	Nicodemus CF Berek JS	2005	Expert Rev Anticancer Ther2005，5，1：	1
14	Survival of patients following secondary cytoreductive surgery in ovarian cancer显示文摘	Berek JS Hacker NF Lagasse LD	1983	Obstet Gynecol1983，61，：	1
15	Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer显示文摘	Berek JS Taylor PT Gordon A	2004	J Clin Oncol2004，22，17：	1
16	Con-stitutive production of IL-6 by ovarian cancer cell lines and by primary ovarian tumor cultures显示文摘	Watson JM Sensintaffar JL Berek JS	1990	Cancer Res1990，50，21：	1
17	Oregovomab maintenance monoimmunotherapy does not Improve outcomes in advanced ovarian cancer显示文摘	Berek JS Peyton Taylor William McGuire	2009	J Clin Oncol2009，27，3：	1
18	The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids:a me- ta-analysis显示文摘	Pritts EA Vanness DJ Berek JS	2015	Gynecol Surg2015，12，3：	1
19	An analysis of surgical versus chemotherapeutic intervention for the management of intestinal obstruction in advanced ovarian cancer显示文摘	Bryan D Radbod R Berek J	2004	Int J Gynecol Cancer2004，16，：	1
20	Maturation of the immune response in germinal centers 显示文摘	BEREK C BERGER A APEL M	1991	Cell1991，67，6：	1

返回顶部每页显示：

共14页首页上一页第1页下一页末页 /14 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示